KR850004398A - Waxes, Antigens and Antibodies for Treatment of Kawasaki Disease - Google Patents

Waxes, Antigens and Antibodies for Treatment of Kawasaki Disease Download PDF

Info

Publication number
KR850004398A
KR850004398A KR1019840008490A KR840008490A KR850004398A KR 850004398 A KR850004398 A KR 850004398A KR 1019840008490 A KR1019840008490 A KR 1019840008490A KR 840008490 A KR840008490 A KR 840008490A KR 850004398 A KR850004398 A KR 850004398A
Authority
KR
South Korea
Prior art keywords
streptococcus
antigen
microorganism belonging
mammal
mutant strain
Prior art date
Application number
KR1019840008490A
Other languages
Korean (ko)
Inventor
다까시 쓰루미즈
Original Assignee
요시오까 이사오
기다사도 겡큐쇼(사단법인)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요시오까 이사오, 기다사도 겡큐쇼(사단법인) filed Critical 요시오까 이사오
Publication of KR850004398A publication Critical patent/KR850004398A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

내용 없음No content

Description

[발명의 명칭[Name of invention]

가와사끼병 처리용 왁진, 항원 및 항체Waxes, Antigens and Antibodies for Treatment of Kawasaki Disease

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (9)

I형으로 혈청형과 A형으로 생물형을 갖는 스트레프토코카스. 상기스에 속하는 미생물 또는 그의 변이주의 균체표층의 선모로부터 단리된 항원을 유효성분으로 하고, 스트랩코카스. 상기스에 속하는 미생물의 감염예방 또는 억제용 왁진.Streptococcus having serotype I and biotype A. Strapcocas as an active ingredient, the antigen isolated from the selection of the microorganism belonging to the above or the cell surface layer of the mutant strain thereof. Wax for preventing or inhibiting infection of microorganisms belonging to the above. 미생물의 스트렙토코카스. 상기스벤이주 SSH83(미공연균기 제7372호)인 특허청구의 범위 제1항 기재의 왁진.Streptococcus of microorganisms. The wax described in Claim 1 which is said Svene strain SSH83 (US microbial apparatus No. 7372). 미생물의 스트렙토코카스. 상기스 속하는 미생물 또는 그의 변이주의 치체표면의 선모로부터 단리된 항원을 유효성분으로 하고, 급성열성 피부점막 임파 절증후 예방 또는 억제용 왁진.Streptococcus of microorganisms. Wax for preventing or inhibiting acute febrile mucosal lymphadenopathy as an active ingredient, using the antigen isolated from the stem of the gingiva surface of the microorganism belonging to the above or the mutant strain thereof. 스트렙토코카스. 상기스에 속하는 미생물 또는 그의 변이주의 배양액으로부터 전균체를 분리하고, 자외선으로 불활화하고, 동결건조하는 공정으로 이루어지고, 스트렙토코카스. 상기스감염 증진단용항원의 제조법.Streptococcus. Streptococcus, comprising the steps of separating the whole cells from the culture medium of the microorganism belonging to the above or the mutant strain thereof, inactivating with ultraviolet rays, and lyophilization. The method for preparing the susceptibility enhancing monoclonal antigen. 스트레토코카스. 상기스에 속하는 미생물 또는 그의 변이주의 배양액으로부터 전균체를 분리하고, 이것을 식염수 또는 완충액으로 부유시키고, 가열처리하는 공정으로 이루어지며, 스트렙토코카스. 상기스 치체 추출항원의 제조법.Stretococas. A whole cell is isolated from the culture solution of the microorganism belonging to said strain or its mutant strain, and it is made to float with saline or buffer, and it heat-processes, Streptococcus. Preparation method of the extract extracted antigen. 스트렙토코카스. 상기스에 속하는 미생물 또는 그의 변이주의 배양액으로부터 치체를 제거하고, 암모늄염 또는 금속염으로 처리하는 공정으로 이루어지고, 스트렙토코카스. 상기스의 대사물항원의 제조법.Streptococcus. Streptococcus, comprising a step of removing tooth from a culture solution of a microorganism belonging to the above or a mutant thereof and treating with ammonium salt or a metal salt. Method for preparing metabolite antigens of the above. 스트렙토코카스. 상기스에 속하는 미생물 또는 그의 변이주의 배양액으로부터 전균체를 분리하고, 자외선으로 불활화하며, 동결건조하는 공정으로 얻은 항원으로 포유동물을 면역함으로써, 동물의 체내에 대응하는 항체를 생산하고, 이것을 채취하는 공정으로 이루어지며, 스트렙토코카스. 상기스감염증진 단용 대조혈청의 제조법.Streptococcus. Isolating the whole organism from the culture solution of the microorganism belonging to the above or its mutant strain, immunizing the mammal with an antigen obtained by the step of inactivating by ultraviolet ray and lyophilization, producing a corresponding antibody in the body of the animal, and collecting this The process consists of, streptococcus. Preparation method of the control infection serum for single use. 스트렙토코카스. 상기스에 속하는 미생물을 분리하고, 이것을 식염수 또는 완충액에 부유시켜 가열 처리하는 공정으로 얻은 항원을 포유동물을 면역함으로써, 동물의 체내에 대응하는 항원을 생산하고, 이것을 채취하는 공정으로 이루어지고, 스트렙토코카스. 상기스감염증진단용대조 혈청의 제조법.Streptococcus. Immune the mammal obtained by the step of isolating the microorganism belonging to the above, and floating it in saline or buffer solution to heat the mammal, thereby producing a corresponding antigen in the body of the animal, and comprises a step of collecting this, Strepto Caucas. Method of producing the control serum for diagnosing infection. 스트렙토코카스. 상기스에 속하는 미생물 또는 그의 변이주의 균체표층의 선모로부터 항원을 단리, 이 항원으로 포유동물을 면역함으로써, 대응하는 항체를 포유동물의 체내에서 생산하고, 이것을 채취하는 공정으로 이루어지며, 스트렙토코카스. 상기감염증 예방 또는 억제용항체의 제조법.Streptococcus. Isolation of an antigen from the mother of the cell surface layer of a microorganism belonging to the above or a mutant strain thereof, and immunizing the mammal with this antigen, thereby producing a corresponding antibody in the body of the mammal, and collecting the same, Streptococcus. Method of producing an antibody for preventing or inhibiting the infection. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019840008490A 1983-12-28 1984-12-28 Waxes, Antigens and Antibodies for Treatment of Kawasaki Disease KR850004398A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58-251,976 1983-12-28
JP58251976A JPS60243024A (en) 1983-12-29 1983-12-29 Vaccine for preventing infections disease caused by streptococcus sanguis, and antigen and antibody for diagnosis

Publications (1)

Publication Number Publication Date
KR850004398A true KR850004398A (en) 1985-07-15

Family

ID=17230796

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840008490A KR850004398A (en) 1983-12-28 1984-12-28 Waxes, Antigens and Antibodies for Treatment of Kawasaki Disease

Country Status (2)

Country Link
JP (1) JPS60243024A (en)
KR (1) KR850004398A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60190707A (en) * 1984-03-09 1985-09-28 Advance Res & Dev Co Ltd Cariostatic agent
US10946085B2 (en) * 2016-02-15 2021-03-16 Hipra Scientific, S.L.U. Streptococcus uberis extract as an immunogenic agent

Also Published As

Publication number Publication date
JPS60243024A (en) 1985-12-03

Similar Documents

Publication Publication Date Title
JP2773816B2 (en) Methods for analyzing the presence of Chlamydia infection and species-specific antigens of Chlamydia trachomatis
ES2198405T3 (en) TYPE I SURFACE ANTIGENS ASSOCIATED WITH STAPHYLOCOCCUS EPIDERMIS.
Lancefield Type-specific antigens, M and T, of matt and glossy variants of group A hemolytic streptococci
Raizman et al. Detection of circulating antigen in acute experimental infections with Toxoplasma gondii
DE2967036D1 (en) Vaccine and method of making
Brown et al. Human foamy virus: further characterization, seroepidemiology, and relationship to chimpanzee foamy viruses
DE3175677D1 (en) Polysaccharide antigen from streptococcus and vaccines
Lambert Jr et al. Identification of Actinomyces israelii and Actinomyces naeslundii by fluorescent-antibody and agar-gel diffusion techniques
US5610059A (en) Etiological agent for porcine enteritis
IE940698L (en) Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant
Joly et al. Antigenic analysis of Legionella pneumophila and Tatlockia micdadei (Legionella micdadei) by two-dimensional (crossed) immunoelectrophoresis
Vennes et al. Antigenic analysis of cell structures isolated from Bacillus megaterium
Schachte Immunization of channel catfish, Ictalurus punctatus, against two bacterial diseases
Schmidt et al. Immunodiffusion reactions with rubella antigens
KR850004398A (en) Waxes, Antigens and Antibodies for Treatment of Kawasaki Disease
Jensen Production And Evaluation Of Antisera For Serological Type Determination Of Group‐B Streptococci by Double Diffusion In Agarose Gel
Nayar et al. Infectious bovine keratoconjunctivitis II. Antibodies in lacrimal secretions of cattle naturally or experimentally infected with Moraxella bovis.
Stavitsky Characteristics of pathogenic spirochetes and spirochetoses with special reference to the mechanisms of host resistance
McMillan et al. Serum immunoglobulin response in uncomplicated gonorrhoea.
Reimann et al. AN INDIRECT HAEMAGGLUTINATION TEST FOR DEMONSTRATION OF GONOCOCCAL ANTIBODIES USING GONOCOCCAL PILI AS ANTIGEN: Methodology and Preliminary Results
JPS61185183A (en) Hybrid cell system for producing cell lytic monoclonal antibody to vagina trichomonas
Danielsson et al. Rapid serotyping of groups A, B, and C meningococci by rocket-line immunoelectrophoresis and co-agglutination.
US4539201A (en) Medicament and method for inducing immunity to infectious bovine keratoconjunctivitis
Labzoffsky et al. New complement fixing antigen for serodiagnosis of gonorrhoea
YANO et al. Serological differentiation of bacteria belonging to the Xanthomonas campestris group by indirect hemagglutination test

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid